Replies to post #6595 on ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Smile86, Libigel is designed for women while Androgel is designed for men. Much lower amount Testosterone is used. The transference if any, will be minute.

FDA assess risk vs benefits. The fact that those using Libigel reduce their risk of a Cardiovascular Events by 70% and breast cancer events by a yet to be announced ratio will tip the scales towards FDA approval.

Only a matter of time.

I do agree that even without Libigel, ANIP is a good investment. But ANIP without Libigel will become a Small Cap company. With an approved Libigel you are looking at ANIP becoming a Large Cap Company very quickly.